Figdor CG - Search Results

1

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.

Schuurhuis DH, Lesterhuis WJ, Kramer M, Looman MG, van Hout-Kuijer M, Schreibelt G, Boullart AC, Aarntzen EH, Benitez-Ribas D, Figdor CG, Punt CJ, de Vries IJ, Adema GJ. Schuurhuis DH, et al. Among authors: figdor cg. Cancer Immunol Immunother. 2009 Jul;58(7):1109-15. doi: 10.1007/s00262-008-0626-y. Epub 2008 Nov 19. Cancer Immunol Immunother. 2009. PMID: 19018531 Free PMC article.

2

Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.

Adema GJ, de Boer AJ, van 't Hullenaar R, Denijn M, Ruiter DJ, Vogel AM, Figdor CG. Adema GJ, et al. Among authors: figdor cg. Am J Pathol. 1993 Dec;143(6):1579-85. Am J Pathol. 1993. PMID: 7504884 Free PMC article.

3

Molecular characterization of the melanocyte lineage-specific antigen gp100.

Adema GJ, de Boer AJ, Vogel AM, Loenen WA, Figdor CG. Adema GJ, et al. Among authors: figdor cg. J Biol Chem. 1994 Aug 5;269(31):20126-33. J Biol Chem. 1994. PMID: 7519602 Free article.

4

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.

Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: figdor cg. Int J Cancer. 1995 Jul 4;62(1):97-102. doi: 10.1002/ijc.2910620118. Int J Cancer. 1995. PMID: 7541395 Free article.

5

Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.

Bakker AB, Marland G, de Boer AJ, Huijbens RJ, Danen EH, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: figdor cg. Cancer Res. 1995 Nov 15;55(22):5330-4. Cancer Res. 1995. PMID: 7585596

6

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: figdor cg. J Exp Med. 1994 Mar 1;179(3):1005-9. doi: 10.1084/jem.179.3.1005. J Exp Med. 1994. PMID: 8113668 Free PMC article.

7

Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon alpha.

Vuist WM, Visseren MJ, Otsen M, Bos K, Vyth-Dreese FA, Figdor CG, Melief CJ, Hekman A. Vuist WM, et al. Among authors: figdor cg. Cancer Immunol Immunother. 1993;36(3):163-70. doi: 10.1007/BF01741087. Cancer Immunol Immunother. 1993. PMID: 8439976 Free PMC article.

8

pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.

Adema GJ, Bakker AB, de Boer AJ, Hohenstein P, Figdor CG. Adema GJ, et al. Among authors: figdor cg. Br J Cancer. 1996 May;73(9):1044-8. doi: 10.1038/bjc.1996.202. Br J Cancer. 1996. PMID: 8624261 Free PMC article.

9

Dendritic cells in immune response induction.

Marland G, Bakker AB, Adema GJ, Figdor CG. Marland G, et al. Among authors: figdor cg. Stem Cells. 1996 Sep;14(5):501-7. doi: 10.1002/stem.140501. Stem Cells. 1996. PMID: 8888491 Review.

10

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope.

Bakker AB, van der Burg SH, Huijbens RJ, Drijfhout JW, Melief CJ, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: figdor cg. Int J Cancer. 1997 Jan 27;70(3):302-9. doi: 10.1002/(sici)1097-0215(19970127)70:3<302::aid-ijc10>3.0.co;2-h. Int J Cancer. 1997. PMID: 9033632 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

479 results

Search Page

Filters